Description

Semorelin is a synthetic signaling compound fragment analog of growth hormone-releasing hormone (GHRH), studied in laboratory and animal-model research for its interaction with pituitary GHRH receptors and downstream effects on growth hormone secretion.

Research has explored its role in GH pulsatility and feedback-loop regulation, and its use in preclinical models examining lean mass, energy metabolism, and age-related changes in hormone secretion.

Sermorelin is widely accessible legally in the United States, but only as an individualized formulation prepared by licensed compounding pharmacies (such as 503A or 503B facilities).

This product is intended strictly for in-vitro research or laboratory experimentation by qualified professionals. Any other use is strictly prohibited. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

• For Research use only
• Not for human use
• 99% Pure
• Independent Lab Tested